Article ; Online: Association between implementation of a code stroke system and poststroke epilepsy.
2018 Volume 90, Issue 13, Page(s) e1126–e1133
Abstract: Objective: We aimed to investigate the effect of a code stroke system on the development of poststroke epilepsy.: Methods: We retrospectively analyzed consecutive patients treated with IV thrombolysis under or outside the code stroke system between ... ...
Abstract | Objective: We aimed to investigate the effect of a code stroke system on the development of poststroke epilepsy. Methods: We retrospectively analyzed consecutive patients treated with IV thrombolysis under or outside the code stroke system between 2003 and 2012. Patients were followed up for at least 2 years or until death. Factors with Results: A total of 409 patients met the eligibility criteria. Their median age at stroke onset was 75 years (interquartile range 64-83 years); 220 (53.8%) were male. The median follow-up duration was 1,074 days (interquartile range 119-1,671 days). Thirty-two patients (7.8%) had poststroke seizures during follow-up, comprising 7 (1.7%) with acute symptomatic seizures and 25 (6.1%) with late-onset seizures. Twenty-six patients (6.4%) fulfilled the definition of poststroke epilepsy. Three hundred eighteen patients (77.8%) were treated with the code stroke system while 91 (22.2%) were not. After adjustment for age and stroke etiology, use of the code stroke system was associated with decreased odds of poststroke epilepsy (odds ratio = 0.36, 95% confidence interval 0.14-0.87, Conclusion: The code stroke system was associated with reduced odds and instantaneous risk of poststroke epilepsy. Further studies are required to identify the contribution of the individual components and mechanisms against epileptogenesis after stroke. Classification of evidence: This study provides Class III evidence that for people with acute ischemic stroke, implementation of a code stroke system reduces the risk of poststroke epilepsy. |
---|---|
MeSH term(s) | Aged ; Aged, 80 and over ; Brain Ischemia/complications ; Brain Ischemia/epidemiology ; Brain Ischemia/therapy ; Clinical Protocols ; Disease Management ; Emergency Medical Services/methods ; Epilepsy/epidemiology ; Epilepsy/etiology ; Female ; Fibrinolytic Agents/therapeutic use ; Follow-Up Studies ; Humans ; Incidence ; Male ; Middle Aged ; Retrospective Studies ; Risk Factors ; Stroke/complications ; Stroke/epidemiology ; Stroke/therapy ; Thrombolytic Therapy ; Tissue Plasminogen Activator/therapeutic use |
Chemical Substances | Fibrinolytic Agents ; Tissue Plasminogen Activator (EC 3.4.21.68) |
Language | English |
Publishing date | 2018-02-21 |
Publishing country | United States |
Document type | Journal Article |
ZDB-ID | 207147-2 |
ISSN | 1526-632X ; 0028-3878 |
ISSN (online) | 1526-632X |
ISSN | 0028-3878 |
DOI | 10.1212/WNL.0000000000005212 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Ui II Zs.153: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
|||
Zs.MG 18: Show issues | ||||
Zs.MO 374: Show issues |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.